October 2021 Congress Sessions

Applying AI & ML in Lab Automation

The use of AI to automate molecular design in drug discovery

Darren Green, Head of Cheminformatics and Data Science, GSK

Driving better chemical synthesis with machine learning and lab automation

Jason Stevens, Computer Assisted Synthesis Lead, Bristol Myers Squibb

Joe Barco, Senior Director of Product Marketing, Unchained Labs

This recorded session is part of the Lab of the Future premium content section. It is free for registered users. Please register or submit below

Register for Premium Content

Name*
First Last
Job Title*
Company Name*
Country*
Country
Email*
- Remember me?
Phone
This field is for validation purposes and should be left unchanged.

Related content

Strategies for accelerating Drug Discovery

Strategies for Accelerating Drug Discovery with AI

Pharma and biotech companies must produce safe, efficacious medicines more efficiently than ever to... Read more

Lab of the Future Congress Europe 2023 – Keynote Session 2

Session 2: “Fuelling Drug Discovery: From Creative Ideas to innovative Brain Therapies” – Tarek Samad,... Read more

From the beta amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease

From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s... Read more

Tackling the Digital Talent Challenge in Life Sciences.

How Real Estate and workplace strategies can help. Joanne Henderson, Executive Director, CBRE, 2019 Digital... Read more